Cargando…
Renal and Vascular Effects of Combined SGLT2 and Angiotensin-Converting Enzyme Inhibition
The cardiorenal effects of sodium-glucose cotransporter 2 inhibition (empagliflozin 25 mg QD) combined with angiotensin-converting enzyme inhibition (ramipril 10 mg QD) were assessed in this mechanistic study in patients with type 1 diabetes with potential renal hyperfiltration. METHODS: Thirty pati...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354594/ https://www.ncbi.nlm.nih.gov/pubmed/35862082 http://dx.doi.org/10.1161/CIRCULATIONAHA.122.059150 |